Ted Kennedy Dies at 77
Having beaten his doctors' previous prognosis and living to help usher in a new American administration, Sen. Ted Kennedy succumbed to brain cancer late Tuesday night at his home in Hyannis Port, Mass., at age 77.Having beaten his doctors' previous prognosis, Sen. Ted Kennedy succumbed to brain cancer late Tuesday night.
Having beaten his doctors’ previous prognosis and living to help usher in a new American administration, Sen. Ted Kennedy succumbed to brain cancer late Tuesday night at his home in Hyannis Port, Mass., at age 77. –KA
Like Sisyphus at the top of the hill, Kennedy died a king heartrendingly within view of his lifelong goal: health care for all. The squabbling over options and political maneuvering is all the more crass in this light. Kennedy had the purity of vision, the political genius and the heroic love of the downtrodden necessary to pass, at last, his magnum opus. He just didn’t have the body. –PS
WAIT BEFORE YOU GO...ABC News:
The man known as the “liberal lion of the Senate” had fought a more than year-long battle with brain cancer, and according to his son had lived longer with the disease than his doctors expected him to.
“We’ve lost the irreplaceable center of our family and joyous light in our lives, but the inspiration of his faith, optimism, and perseverance will live on in our hearts forever,” the Kennedy family said in a statement. “He loved this country and devoted his life to serving it.”
This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.
At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.
Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.
Don’t settle for surface-level coverage.
Unearth what matters. Help dig deeper.
Donate now.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.